See the DrugPatentWatch profile for cosentyx

The initial Cosentyx (secukinumab) dosage for adults is as follows:

For the treatment of moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis, the recommended dosage of Cosentyx is 300 mg. This dosage is administered via subcutaneous injection. For psoriatic arthritis and ankylosing spondylitis, the initial dose is followed by 300 mg every 4 weeks. For plaque psoriasis, the initial dose is followed by 300 mg every 4 weeks for the first 3 doses, and then 300 mg every 8 to 12 weeks thereafter [1].

It is important to note that the dosage may vary based on the patient's weight, renal function, and other factors. Healthcare professionals will determine the appropriate dosage for each individual patient.

Sources:
[1] DrugPatentWatch.com. Cosentyx (secukinumab) Dosage. <https://www.drugpatentwatch.com/cosentyx-secukinumab-dosage.html>.